TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Biotage AB
Closing information (x1000 SEK)
| Closing information | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Turnover |
2,056,000
|
1,862,000
|
1,566,000 |
| Financial expenses |
67,000
|
41,000
|
14,000 |
| Earnings before taxes |
328,000
|
303,000
|
348,000 |
| EBITDA |
568,000
|
463,000
|
429,000 |
| Total assets |
5,104,000
|
4,931,000
|
2,339,000 |
| Current assets |
1,358,000
|
1,447,000
|
1,031,000 |
| Current liabilities |
578,000
|
701,000
|
414,000 |
| Equity capital |
4,113,000
|
3,657,000
|
1,637,000 |
| - share capital |
113,000
|
112,000
|
93,000 |
| Employees (average) |
673
|
674
|
517 |
Financial ratios
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Solvency |
80.6%
|
74.2%
|
70.0% |
| Turnover per employee |
3,055
|
2,763
|
3,029 |
| Profit as a percentage of turnover |
16.0%
|
16.3%
|
22.2% |
| Return on assets (ROA) |
7.7%
|
7.0%
|
15.5% |
| Current ratio |
234.9%
|
206.4%
|
249.0% |
| Return on equity (ROE) |
8.0%
|
8.3%
|
21.3% |
| Change turnover |
194,000
|
296,000
|
334,000 |
| Change turnover % |
10%
|
19%
|
27% |
| Chg. No. of employees |
-1
|
157
|
20 |
| Chg. No. of employees % |
0%
|
30%
|
4% |
Total value of public sale
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.